| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5654877 | Clinical Immunology | 2017 | 8 Pages |
Abstract
Since anti-Gal result from an immunization against α1,3 Gal, lacking in humans but produced in the gut, our data suggest that CIS and MS patients have an altered microbiota or an altered response to this microbiotic epitope.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
L. Le Berre, J. Rousse, P.-A. Gourraud, B.-M. Imbert-Marcille, A. Salama, G. Evanno, G. Semana, A. Nicot, E. Dugast, P. Guérif, C. Adjaoud, T. Freour, S. Brouard, F. Agbalika, R. Marignier, D. Brassat, D.-A. Laplaud, E. Drouet, J.-P. Soulillou,